Effect of Shikonin on the COX-2 Expression of Synoviai Fibroblasts in Rheumatoid Arthritis

ZHANG Yong-hong,YU Hui-min,NIE Ying-kun
DOI: https://doi.org/10.3969/j.issn.1000-1905.2012.03.016
2012-01-01
Abstract:Objective To investigate the effect of shikonin on the cyclooxygenase-2(COX-2) mRNA expression in synovial fibroblasts and the immune anti-inflammatory mechanism of shikonin.Methods Isolated and cultured synovial membrane fibroblasts,added IL-1β,TNF-α15 ng/mL respectively,human synovial cells of rheumatoid arthritis were simulated in vitro.As a positive control of celecoxib,synovial fibroblasts were interfered with shikonin in concentration of 5~80 μg/L,then cultured for 24 h,48 h and 72 h.Semi-quantitative reverse transcription-polymerase chain reaction(RT-PCR) was used to detect the COX-2 mRNA expression of synovial fibroblasts.Results COX-2 mRNA expression of synovial fibroblasts was significantly dependent on medication time(P0.0001),not on the concentration(P=0.089).Celecoxib significantly inhibit the synovial fibroblasts and showed that the level of COX-2 mRNA expression without sinificant concentration-dependence(P=0.051),only with medication time(P0.0001).Compared with celecoxib,the COX-2 mRNA expression effected by shikonin on synovial fibro-blasts had no significant difference in inhibititon.Conclusion Shikonin can inhibit COX-2 mRNA expression and reduce the production of inflammatory cytokines in order to play its immune anti-inflammatory role in rheumatoid arthritis.This study could provide some experimental basis for the development of shikonin as a COX-2 inhibitor.
What problem does this paper attempt to address?